Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|November 6, 2009
Outcomes of childhood hemangiomas treated with the pulsed-dye laser with dynamic cooling: a retrospective chart analysisCarina Rizzo, Lori Brightman, Anne M Chapas, et al.Biophysical Journal|June 4, 2021
Depletion of HP1α alters the mechanical properties of MCF7 nucleiSusav Pradhan, Raoul Solomon, Ankita Gangotra, et al.Chest|March 1, 1991
Treatment of end-stage chronic obstructive pulmonary disease with double lung transplantationR W Emery, J L Graif, K Hale, et al.The British Journal of Dermatology|March 25, 2005
Association of melanoma and neurocutaneous melanocytosis with large congenital melanocytic naevi--results from the NYU-LCMN registryE K Hale, J Stein, L Ben-Porat, et al.Journal of Veterinary Medical Education|November 19, 2019
Development and Evolution of the Clinical Skills Learning Center as an Integral Component of the Illinois Veterinary Professional CurriculumDawn E Morin, Connie J Arnold, Lorrie K Hale-Mitchell, et al.Journal of the American Academy of Dermatology|October 9, 2012
1927-nm fractional resurfacing of facial actinic keratoses: a promising new therapeutic optionElliot T Weiss, Jeremy A Brauer, Robert Anolik, et al.Archives of Dermatology|July 18, 2012
Successful and rapid treatment of blue and green tattoo pigment with a novel picosecond laserJeremy A Brauer, Kavitha K Reddy, Robert Anolik, et al.Proceedings of the National Academy of Sciences of the United States of America|November 1, 1990
A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitorT Kohno, M T Brewer, S L Baker, et al.Cytokine|January 1, 1995
Multifunctional regulation of the biological effects of TNF-alpha by the soluble type I and type II TNF receptorsK K Hale, C G Smith, S L Baker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Phase I trial of weekly scheduling and pharmacokinetics of titanocene dichloride in patients with advanced cancerC V Christodoulou, D R Ferry, D W Fyfe, et al.Pageof 9